The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Management of Menopausal Symptoms
Open accessAbstract
Most menopausal women experience vasomotor symptoms with bothersome symptoms often lasting longer than one decade. Hormone therapy (HT) represents the most effective treatment for these symptoms with oral and transdermal estrogen formulations having comparable efficacy. Findings from the Women's Health Initiative and other recent randomized clinical trials have helped to clarify the benefits and risks of combination estrogen-progestin and estrogen-alone therapy. Absolute risks observed with HT tended to be small, especially in younger women. Neither regimen increased all-cause mortality rates. Given the lower rates of adverse events on HT among women close to menopause onset and at lower baseline risk of cardiovascular disease, risk stratification and personalized risk assessment appear to represent a sound strategy for optimizing the benefit-risk profile and safety of HT. Systemic HT should not be arbitrarily stopped at age 65 years; instead treatment duration should be individualized based on patients' risk profiles and personal preferences. Genitourinary syndrome of menopause represents a common condition that adversely affects the quality of life of many menopausal women. Without treatment, symptoms worsen over time. Low-dose vaginal estrogen represents highly effective treatment for this condition. Because custom-compounded hormones have not been tested for efficacy or safety, U.S. Food and Drug Administration (FDA)-approved HT is preferred. A low-dose formulation of paroxetine mesylate currently represents the only nonhormonal medication FDA-approved to treat vasomotor symptoms. Gynecologists and other clinicians who remain abreast of data addressing the benefit-risk profile of hormonal and nonhormonal treatments can help menopausal women make sound choices regarding management of menopausal symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
A Study of sexuality and health among older adults in the United States
Lindau, S. T., Schumm, L. P., Laumann, E. O., Levinson, W., O'Muircheartaigh, C. A., & Waite, L. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067423 · Cited by 2,211
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Self-citationModerate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk
Chen, W. Y., Rosner, B., Hankinson, S. E., Colditz, G. A., & Willett, W. C. (2011) · JAMA · doi:10.1001/jama.2011.1590 · Cited by 509 · cited 1×
“28 is slightly higher than that seen with one daily glass of wine and less than that noted with two daily glasses.(35) In the conjugated equine estrogens plus medroxyprogesterone acetate trial, a nonsignificantly elevated risk of ovarian cancer also was identified over 13 years of cumulative follow-up (94 cases; HR 1.”
BackgroundFreedman, R. R. (2001) · American Journal of Human Biology · doi:10.1002/ajhb.1077 · Cited by 369
Reduced thermoregulatory null zone in postmenopausal women with hot flashes.
Freedman, R. R., & Krell, W. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70437-0 · Cited by 309
Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial
Elkins, G. R., Fisher, W. I., Johnson, A. K., Carpenter, J. S., & Keith, T. Z. (2013) · Menopause · doi:10.1097/gme.0b013e31826ce3ed · Cited by 208 · cited 1×
“001).(12) The effectiveness of acupuncture,(13) exercise,(14) yoga,(15) paced respiration,(16) relaxation training,(17) and mindfulness-based stress reduction(18) has not been established.”
BackgroundMindfulness training for coping with hot flashes: results of a randomized trial
Carmody, J. F., Crawford, S., Salmoirago-Blotcher, E., Leung, K., Churchill, L., & Olendzki, N. (2011) · Menopause · doi:10.1097/gme.0b013e318204a05c · Cited by 188
Cited by
Cardiovascular Disease in Women: Clinical Perspectives
Garcia, M., Mulvagh, S. L., Bairey Merz, C. N., Buring, J. E., & Manson, J. E. (2016) · Circulation Research · doi:10.1161/circresaha.116.307547 · Cited by 1,080
Self-citationEffects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
Goldštajn, M. Š., Mikuš, M., Ferrari, F. A., Bosco, M., Uccella, S., Noventa, M., Török, P., Terzic, S., Laganà, A. S., & Garzon, S. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06647-5 · Cited by 111
Metadata
- Authors
- Kaunitz, A. M., & Manson, J. E.
- Venue
- Obstetrics & Gynecology
- Published
- 2015-10
- Volume
- 126
- Issue
- 4
- Pages
- 859-876
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2303286930
- Cited by
- 191
- References
- 12
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Menopausal Symptoms. https://app.cochat.ai/papers/10.1097/aog.0000000000001058
- The paper
- Kaunitz, A. M., & Manson, J. E. (2015). Management of Menopausal Symptoms. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000001058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.